Your browser doesn't support javascript.
loading
Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.
Abdullahi, Idris Nasir; Emeribe, Anthony Uchenna; Adekola, Hafeez Aderinsayo; Abubakar, Sharafudeen Dahiru; Dangana, Amos; Shuwa, Halima Ali; Nwoba, Sunday Theophilus; Mustapha, Jelili Olaide; Haruna, Muyideen Titilope; Olowookere, Kafayat Adepeju; Animasaun, Olawale Sunday; Ugwu, Charles Egede; Onoja, Solomon Oloche; Gadama, Abdullahi Sani; Mohammed, Musa; Daneji, Isa Muhammad; Amadu, Dele Ohinoyi; Ghamba, Peter Elisha; Onukegbe, Nkechi Blessing; Shehu, Muhammad Sagir; Isomah, Chiladi; Babayo, Adamu; Ahmad, Abdurrahman El-Fulaty.
Afiliação
  • Abdullahi IN; Department of Medical Laboratory Science, Faculty of Allied Health Sciences, College of Medical Sciences, Ahmadu Bello University, Zaria, Nigeria.
  • Emeribe AU; Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, University of Calabar, Calabar, Nigeria.
  • Adekola HA; Department of Microbiology, Olabisi Onabanjo University, Ago-Iwoye, Nigeria.
  • Abubakar SD; Department of Medical Laboratory Science, Faculty of Allied Health Sciences, College of Medical Sciences, Ahmadu Bello University, Zaria, Nigeria.
  • Dangana A; Department of Medical Laboratory Services, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria.
  • Shuwa HA; Lydia Becker Institute of Immunology, Manchester Collaborative Center for Inflammation Research, Faculty of Biology, Medicine and Health, The University of Manchester, UK.
  • Nwoba ST; Department of Chemical and Process Engineering, University of Canterbury, New Zealand.
  • Mustapha JO; Biological Sciences Department, Faculty of Science, University of Alberta, Edmonton, Canada.
  • Haruna MT; Department of Biology, Dixon Research Center, Morgan State University, Baltimore, USA.
  • Olowookere KA; Department of Medical Laboratory Services, Ladoke Akintola University of Technology Teaching Hospital, Ogbomoso, Nigeria.
  • Animasaun OS; Nigeria Field Epidemiology and Laboratory Training Programme, African Field Epidemiology Network, Abuja, Nigeria.
  • Ugwu CE; Department of Medical Laboratory Science, Ebonyi State University, Abakaliki, Nigeria.
  • Onoja SO; Department of Medical Laboratory Science, University of Nigeria, Enugu, Nigeria.
  • Gadama AS; Department of Medical Microbiology and Parasitology, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria.
  • Mohammed M; Department of Medicine, Immunology Unit, Ahmadu Bello University, Zaria, Nigeria.
  • Daneji IM; Department of Medical Microbiology and Parasitology, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria.
  • Amadu DO; Department of Medical Microbiology and Parasitology, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
  • Ghamba PE; WHO National Polio Reference Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
  • Onukegbe NB; Department of Strategic Information and Research, Institute of Human Virology, Abuja, Nigeria.
  • Shehu MS; Medical Laboratory Department, College of Health Technology, Ningi, Bauchi State, Nigeria.
  • Isomah C; Medical Laboratory Science Department, Rivers State University, Port Harcourt, Nigeria.
  • Babayo A; Department of Medical Microbiology and Parasitology, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria.
  • Ahmad AE; Department of Medical Laboratory Science, Faculty of Allied Health Sciences, College of Medical Sciences, Ahmadu Bello University, Zaria, Nigeria.
Hum Vaccin Immunother ; 17(3): 620-637, 2021 03 04.
Article em En | MEDLINE | ID: mdl-32936732
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article